Incannex regains compliance with Nasdaq minimum bid price rule

Incannex (IXHL) Healthcare has regained compliance with the Nasdaq minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2). The Company received written confirmation from The Nasdaq Stock Market LLC that it has regained compliance with the minimum bid price requirement after its common stock maintained a closing bid price of $1.00 per share or greater for eleven consecutive business days, from February 27 through March 13, 2026. As a result, the Company has satisfied the requirements for continued listing on the Nasdaq Capital Market, and the matter is now considered closed.